A high-risk growth-stage biotechnology and materials engineering firm attempting to commercialize proprietary electrokinetic technologies after a period of significant capital raising and operational restructuring.
Investors might buy CRKN seeking early exposure to disruptive electrokinetic technology with the potential for exponential returns if commercialization scales successfully. The recent revenue spike indicates market validation of their product or service, offering a turnaround opportunity before widespread adoption occurs. Significant cash inflows from share issuances suggest strong investor confidence in the long-term viability of their core technology.
The company remains unprofitable with a retained earnings deficit exceeding $142 million, signaling that historical operations have consistently burned through capital without generating sustainable earnings. Revenue growth is precarious and entirely dependent on continued equity dilution rather than organic cash flow generation from operations. The massive negative operating cash flow of -$18.2 million creates an existential risk if the company cannot secure further financing or achieve profitability within a few quarters.
Crown Electrokinetics Corp. (CRKN) is a specialized technology firm focused on electrokinetic systems and advanced material processing solutions. The company primarily serves industrial sectors requiring high-precision energy conversion and filtration technologies, leveraging proprietary research and development to engineer next-generation equipment.
The company reported a net loss of $25.9 million in 2024, an improvement over the $29.0 million loss in 2023, yet still reflects deep structural losses typical of early-stage technology development. Revenue surged to $19.7 million from negligible levels in 2023, suggesting a major commercial milestone or strategic partnership was achieved, but this growth was not sufficient to cover operating expenses which totaled $23.4 million. Cash reserves remain robust at $13.7 million, providing approximately 18 months of runway based on current burn rates.
The electrokinetic technology industry is a high-barrier, R&D-intensive sector focused on energy efficiency and specialized industrial processing where early movers can capture significant market share. Competition typically comes from established chemical engineering firms and emerging startups with deep pockets for long development cycles. Success in this niche depends heavily on securing strategic partnerships and navigating complex regulatory environments regarding industrial safety and emissions.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $153.0K | $19.7M |
| Cost of Revenue | $0 | $886.0K | $20.4M |
| Gross Profit | $0 | $-733.0K | $-714.0K |
| Operating Expenses | $15.1M | $18.6M | $23.4M |
| Operating Income | $-15.1M | $-19.3M | $-24.1M |
| R&D | $4.1M | $2.2M | $3.4M |
| G&A | $11.0M | $15.0M | $20.0M |
| Stock-Based Comp | $923.0K | $714.0K | $5.2M |
| D&A | $503.0K | $733.0K | $1.1M |
| Depreciation | $46.0K | $500.0K | $900.0K |
| Amortization | $200.0K | $400.0K | $200.0K |
| Other OpEx | $0 | $1.4M | $0 |
| Non-Operating Income | $0 | $-9.7M | $-1.8M |
| Interest Expense | $7.0K | $9.4M | — |
| Pre-Tax Income | $-15.1M | $-29.0M | $-25.9M |
| Income Tax | $-793.0K | $0 | $0 |
| Continuing Ops | $-14.3M | $-29.0M | $-25.9M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-14.3M | $-29.0M | $-25.9M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-14.3M | $-29.0M | $-25.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $1.4M | $1.9M | $23.6M |
| Cash & Equivalents | — | $1.1M | $13.7M |
| Accounts Receivable | — | $83.0K | $5.4M |
| Prepaid Expenses | $590.0K | $728.0K | $2.4M |
| Other Current Assets | $821.0K | $0 | $2.1M |
| Long-Term Assets | $5.2M | $7.7M | $11.4M |
| PP&E (Net) | $1.4M | $3.1M | $8.3M |
| Intangibles | $1.6M | — | — |
| Goodwill | — | $652.0K | — |
| Operating Leases | $1.8M | $1.7M | $1.8M |
| Other LT Assets | $330.0K | $2.2M | $1.3M |
| Total Assets | $6.6M | $9.5M | $35.0M |
| Current Liabilities | $4.7M | $3.8M | $11.1M |
| Accounts Payable | $865.0K | $1.5M | — |
| Current Leases | $574.0K | $655.0K | $618.0K |
| Deferred Revenue | — | $2.0K | — |
| Taxes Payable | — | $51.0K | — |
| Other Current Liab | $2.6M | $378.0K | $5.7M |
| Long-Term Liabilities | $1.4M | $1.1M | $1.7M |
| LT Operating Leases | $1.4M | $1.1M | $984.0K |
| Other LT Liab | $0 | $-100.0M | $679.0K |
| Total Liabilities | $6.1M | $4.8M | $12.7M |
| Shareholders' Equity | $530.0K | $4.7M | $22.2M |
| Paid-In Capital | $88.5M | $121.7M | $165.2M |
| Retained Earnings | $-88.0M | $-117.0M | $-142.9M |
| Total L&E | $6.6M | $9.5M | $35.0M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-14.3M | $-29.0M | $-25.9M |
| Non-Cash Adjustments | $3.3M | $12.2M | $-5.0M |
| Working Capital Changes | $-165.0K | $653.0K | $12.8M |
| Cash from Operations | $-11.1M | $-16.2M | $-18.2M |
| Capital Expenditures | — | $2.2M | $6.1M |
| Cash from Investing | $-812.0K | $-2.8M | $-6.2M |
| Cash from Financing | $6.6M | $19.2M | $37.0M |
| FX Effect | $0 | $2.0K | $0 |
| Net Change in Cash | $-5.3M | $238.0K | $12.6M |
| Beginning Cash | $6.1M | $821.0K | $1.1M |
| Ending Cash | $821.0K | $1.1M | $13.7M |
The company's financial profile suggests revenue is driven by the sale of specialized electrokinetic hardware or licensing agreements, with substantial R&D expenses indicating a focus on developing new product lines. Operating segments likely include equipment manufacturing, technology licensing to industrial partners, and potentially pilot-scale project development, though current operations show minimal gross profit.
Persistent operating losses of approximately $26 million in 2024, indicating the business model has not yet achieved commercial profitability. Heavy reliance on external equity financing, evidenced by $37 million in cash flow from financing activities, to fund operations and capital expenditures. High burn rate coupled with minimal revenue growth from near-zero levels in 2023 poses a sustainability risk without successful product launches.
Access to proprietary electrokinetic patents that may provide a technological barrier to entry in niche industrial applications. Strong balance sheet liquidity relative to liabilities following recent capital raises, offering flexibility for R&D investment. A management team with deep expertise in specialized material science and energy conversion systems.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.